Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Case report

Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report

Authors: Keiichi Arakawa, Keisuke Hata, Yoko Yamamoto, Takeshi Nishikawa, Toshiaki Tanaka, Tomomichi Kiyomatsu, Kazushige Kawai, Hiroaki Nozawa, Masafumi Yoshida, Hiroshi Fukuhara, Mitsuhiro Fujishiro, Teppei Morikawa, Tatsuya Yamasoba, Kazuhiko Koike, Masashi Fukayama, Toshiaki Watanabe

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Although cases of multiple primary malignant neoplasms are increasing, reports of more than three or four primary metachronous malignant neoplasms are extremely rare. Moreover, very few publications have provided a genetic mutational analysis or have evaluated risk factors associated with such neoplasms. We present an extremely rare case of nine primary malignant lesions in a man who was successfully treated. We also report on microsatellite stability status, analyze risk factors, and discuss the relevant literature.

Case presentation

Between 67 and 73 years of age, a male patient developed nine primary metachronous malignant lesions: Three were located in the esophagus, two in the stomach, two in the colorectum, one in the prostate gland, and one in the external ear canal. The patient’s clinical history included hypertension, atrial fibrillation, an acoustic schwannoma, and heavy smoking. The lesions were diagnosed during regular screening over a six-year period. He was successfully treated with surgery (both open surgical and endoscopic resection of lesions) and adjuvant chemotherapy. Immunohistochemistry and mutational analysis showed that the lesions were microsatellite stable, and the KRAS, BRAF, p53, and nuclear β-catenin status was not uniform among the lesions.

Conclusions

Given that the presence of more than three or four neoplasms is extremely rare, the present case of nine primary malignancies with no associated microsatellite instability and no apparent predisposing hereditary conditions, is extraordinary. Our case study shows that it is possible for up to nine sporadic neoplasms to occur, and efficient disease management requires diligent screening and early detection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26:79–83.CrossRefPubMed Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26:79–83.CrossRefPubMed
2.
go back to reference LL X, Clinical GKS. Retrospective analysis of cases with multiple primary malignant neoplasms. Genet Mol Res. 2014;13:9271–84.CrossRef LL X, Clinical GKS. Retrospective analysis of cases with multiple primary malignant neoplasms. Genet Mol Res. 2014;13:9271–84.CrossRef
3.
go back to reference Zhao J, Tan Y, Wu Y, Zhao W, Whu J, Ji M, et al. A rare case of eight multiple primary malignant neoplasms in a female patient: a case report and review of the literature. Oncol Lett. 2015;9:587–90.CrossRefPubMed Zhao J, Tan Y, Wu Y, Zhao W, Whu J, Ji M, et al. A rare case of eight multiple primary malignant neoplasms in a female patient: a case report and review of the literature. Oncol Lett. 2015;9:587–90.CrossRefPubMed
4.
go back to reference Swaroop VS, Winawer SJ, Lightdale CJ, Lipkin M. Six primary cancers in individuals. Report of four cases. Cancer. 1988;61:1253–4.CrossRefPubMed Swaroop VS, Winawer SJ, Lightdale CJ, Lipkin M. Six primary cancers in individuals. Report of four cases. Cancer. 1988;61:1253–4.CrossRefPubMed
5.
go back to reference Hata K, Watanabe T, Kawamura YJ, Ishigami H, Kanazawa T, Tada T, et al. K-ras mutation and loss of heterozygosity at 17p with beta-catenin accumulation in intramucosal carcinoma of the ileostomy in familial adenomatous polyposis: a case report. Dig Dis Sci. 2003;48:2310–4.CrossRefPubMed Hata K, Watanabe T, Kawamura YJ, Ishigami H, Kanazawa T, Tada T, et al. K-ras mutation and loss of heterozygosity at 17p with beta-catenin accumulation in intramucosal carcinoma of the ileostomy in familial adenomatous polyposis: a case report. Dig Dis Sci. 2003;48:2310–4.CrossRefPubMed
6.
go back to reference Tanaka J, Watanabe T, Kanazawa T, Tada T, Kazama Y, Tanaka T, et al. Left-sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones. J Surg Oncol. 2007;96:611–8.CrossRefPubMed Tanaka J, Watanabe T, Kanazawa T, Tada T, Kazama Y, Tanaka T, et al. Left-sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones. J Surg Oncol. 2007;96:611–8.CrossRefPubMed
7.
go back to reference Wang HL, Zhou PY, Liu P, Zhang Y. ALDH2 and ADH1 genetic polymorphisms may contribute to the risk of gastric cancer: a meta-analysis. PLoS One. 2014;9:e88779.CrossRefPubMedPubMedCentral Wang HL, Zhou PY, Liu P, Zhang Y. ALDH2 and ADH1 genetic polymorphisms may contribute to the risk of gastric cancer: a meta-analysis. PLoS One. 2014;9:e88779.CrossRefPubMedPubMedCentral
8.
go back to reference Crous-Bou M, Rennert G, Cuadras D, Salazar R, Cordero D, Saltz Rennert H, et al. Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer. PLoS One. 2013;8:e80158.CrossRefPubMedPubMedCentral Crous-Bou M, Rennert G, Cuadras D, Salazar R, Cordero D, Saltz Rennert H, et al. Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer. PLoS One. 2013;8:e80158.CrossRefPubMedPubMedCentral
9.
go back to reference Kim SH, Park BS, Kim HS, Kim JH. Synchronous quintuple primary gastrointestinal tract malignancies: case report. World J Gastroenterol. 2017;23:173–7.CrossRefPubMedPubMedCentral Kim SH, Park BS, Kim HS, Kim JH. Synchronous quintuple primary gastrointestinal tract malignancies: case report. World J Gastroenterol. 2017;23:173–7.CrossRefPubMedPubMedCentral
10.
go back to reference Yakushiji H, Mukai S, Matsukura S, Sato S, Ogawa A, Sasatomi E, et al. DNA mismatch repair deficiency in curatively resected sextuple primary cancers in different organs: a molecular case report. Cancer Lett. 1999;142:17–22.CrossRefPubMed Yakushiji H, Mukai S, Matsukura S, Sato S, Ogawa A, Sasatomi E, et al. DNA mismatch repair deficiency in curatively resected sextuple primary cancers in different organs: a molecular case report. Cancer Lett. 1999;142:17–22.CrossRefPubMed
11.
go back to reference Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138:2088–100.CrossRefPubMed Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138:2088–100.CrossRefPubMed
12.
go back to reference Hata K, Yamamoto Y, Kiyomatsu T, Tanaka T, Kazama S, Nozawa H, et al. Hereditary gastrointestinal cancer. Surg Today. 2016;46:1115–22.CrossRefPubMed Hata K, Yamamoto Y, Kiyomatsu T, Tanaka T, Kazama S, Nozawa H, et al. Hereditary gastrointestinal cancer. Surg Today. 2016;46:1115–22.CrossRefPubMed
13.
go back to reference Moisio AL, Järvinen H, Peltomäki P. Genetic and clinical characterisation of familial adenomatous polyposis: a population based study. Gut. 2002;50:845–50.CrossRefPubMedPubMedCentral Moisio AL, Järvinen H, Peltomäki P. Genetic and clinical characterisation of familial adenomatous polyposis: a population based study. Gut. 2002;50:845–50.CrossRefPubMedPubMedCentral
14.
go back to reference Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017;3:464–71.CrossRefPubMed Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017;3:464–71.CrossRefPubMed
15.
go back to reference Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.CrossRef Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.CrossRef
16.
go back to reference Balschun K, Haag J, Wenke AK, von Schonfels W, Schwarz NT, Rocken C. KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary colorectal cancers diagnostic and therapeutic implications. J Mol Diagn. 2011;13:436–45.CrossRefPubMedPubMedCentral Balschun K, Haag J, Wenke AK, von Schonfels W, Schwarz NT, Rocken C. KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary colorectal cancers diagnostic and therapeutic implications. J Mol Diagn. 2011;13:436–45.CrossRefPubMedPubMedCentral
17.
go back to reference Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med. 2009;24:6:e50. Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med. 2009;24:6:e50.
Metadata
Title
Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report
Authors
Keiichi Arakawa
Keisuke Hata
Yoko Yamamoto
Takeshi Nishikawa
Toshiaki Tanaka
Tomomichi Kiyomatsu
Kazushige Kawai
Hiroaki Nozawa
Masafumi Yoshida
Hiroshi Fukuhara
Mitsuhiro Fujishiro
Teppei Morikawa
Tatsuya Yamasoba
Kazuhiko Koike
Masashi Fukayama
Toshiaki Watanabe
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3973-2

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine